Travere Therapeutics (TVTX) Change in Intangibles (2013 - 2026)

Travere Therapeutics has reported Change in Intangibles for 14 years, with the latest figure at $22.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Intangibles rose 88.2% year-over-year to $22.2 million; the trailing twelve-month figure through Mar 2026 stood at $68.4 million (up 121.22% YoY), and the FY2025 full-year result was $58.2 million, up 60.6% from the prior year.
• Change in Intangibles for Q1 2026 stood at $22.2 million, up from $19.2 million in the prior quarter.
• The five-year high for Change in Intangibles was $23.0 million in Q1 2023, with the low at $500000.0 in Q2 2023.
• Historically, Change in Intangibles has averaged $9.7 million across 5 years, with a median of $7.6 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Intangibles sank 95.63% — and 2024, when it surged 720.0%.
• Travere Therapeutics' Change in Intangibles stood at $4.2 million in 2022, then jumped by 32.11% to $5.5 million in 2023, then soared by 75.17% to $9.6 million in 2024, then surged by 99.51% to $19.2 million in 2025, then advanced by 15.28% to $22.2 million in 2026.
• The last three Change in Intangibles figures came in at $22.2 million (Q1 2026), $19.2 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.